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Regarding: “Endovascular management of
spontaneous carotid artery dissection”
In the present global enthusiasm for endovascular stenting, a
procedure easy to perform and relatively safe in experienced hands,
we feel there is a serious danger of losing clinical perspective. The
recent article by Edgell et al1 describing the stenting of dissected
carotid arteries warrants especially careful evaluation.
The indications for this procedure in a dissected vessel are far
from well defined and relevant to the otherwise benign outcome of
carotid dissection with a spontaneous recurrence rate of only 1% to
2% per year.2 Dissected arteries cannot be equated with atheroscle-
rotic stenosis, because there is a selective vulnerability, probably in
all arteries throughout the body, in these patients due to a genet-
ically determined segmental medial arteriopathy.3
Inserting a stent in these fragile vessels may increase or even
cause further dissection, as occurred in one of the patients in their
case series.1 There is also the potential of the stent, which can be
inserted at an inappropriate time after arterial occlusion, releasing a
pressure head of blood into freshly infarcted tissue (as in case 2),
producing hemorrhagic conversion of an otherwise benign lesion.
This is a time-limiting factor in thrombolytic treatment of ischemic
stroke.
As cautious neurologists, we therefore cannot concur with
Dr Mackey that “. . . aggressive early stenting of traumatic and
spontaneous carotid dissections now warrant careful study.” We
should hasten slowly, primum non nocere.
John W Norris MD
Ranjith K Menon MD
Division of Clinical Neuroscience
St George’s University of London
London, United Kingdom
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I must take issue with the letter from Drs. Norris and Menon.
The report from Drs Edgell, Abou-Chebl and Yadav does not
include cases of uncomplicated carotid dissection and the authors
are not recommending intervention for uncomplicated dissections.
Only 5% of their 135 patients with spontaneous dissection were
treated with stents, and these patients had expanding or symptom-
atic pseudoaneurysms or severe symptomatic flow compromise
because of multi-vessel involvement. What were the treatment
alternatives? The severity of the clinical presentation in these
patients (5 with acute stroke and two with symptomatic expanding
pseudoaneurysms) suggests that watchful waiting was not likely to
be a successful strategy. To quote Shakespeare “. . .diseases des-
perate grown by desperate appliance are relieved, or not at all.”
(Hamlet IV,iii).
Nowhere in their manuscript do Drs Edgell, et al equate
stenting for dissection with stenting for atherosclerotic disease.
They describe in detail their painstaking methods for insuring
cannulation of the true lumen and for avoiding extending the
dissection or entering pseudoaneurysms. Endovascular treatment
of carotid dissections is not a procedure for the carotid stenting
neophyte, and the authors make this very clear.
Drs. Norris and Menon suggest that carotid stenting for
dissection might be accompanied by reperfusion cerebral edema or
hemorrhage, and, in fact, intracranial hemorrhage did occur in one
patient 13 days after the procedure. Intracranial hemorrhage fol-
lowing stroke can occur as a result of anticoagulation as well as
reperfusion, and is most likely to occur in those with very poor
baseline perfusion and significant infarction. The outcome in this
patient may have been even worse without intervention as the
patient was nearly comatose at presentation.
Finally, Drs Norris and Menon feel that we should not move
ahead with a trial to examine the efficacy of more liberal use of
stenting in cases of traumatic and spontaneous carotid dissection.
The principal of “primum non nocere” compels a careful balancing
of risks and benefits prior to any intervention. However, up to 15%
of patients with spontaneous dissection fail medical management,
and many patients with post-traumatic dissection develop strokes
several hours or even days post injury. Many of these are young,
previously healthy individuals for whom a stroke is especially devas-
tating. Why not thoroughly and carefully evaluate every potential
means for preventing such strokes?
William C. Mackey, MD
Division of Vascular Surgery
Tufts New England Medical Center
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We read with interest the comments offered by Drs. Norris
andMenon regarding our article describing stenting for symptom-
atic cervicocranial arterial dissection. We, like Drs. Norris and
Menon, are also “cautious neurologists” and do not undertake
endovascular procedures without just cause. Although spontane-
ous arterial dissections do have a generally benign course, not all
patients recover spontaneously without recurrent or continued
ischemia.1 As we clearly described in the article, the patients we
treated represented approximately 5% of the dissection patients
seen in our institution, and all had either ongoing ischemia or
expanding pseudoaneurysms with increasing mass effect, cranial
neuropathy, or intractable headaches. Three of the patients were in
fact in the midst of a large clinical stroke, which resolved or began
to improve immediately after stenting; the stroke would have likely
been fatal in two of these patients and devastating neurologically in
the other. Much of what we as physicians do on a daily basis in the
practice of medicine relies on skill and art as much as it does on
scientific knowledge. Leaving patients such as ours to complete
large hemispheric strokes because some retrospective, historical
data suggest that most patients have an “otherwise benign out-
come” is careless medicine. Furthermore, most of the natural
history data available in the literature do not include large numbers
of patients such as ours who had multiple simultaneous dissections
and flow-limiting lesions with poor cerebral blood flow. The
medical treatment offered to patients with dissections is in fact
therapy aimed at the prevention of thrombosis and thromboem-
bolism, not therapy aimed at augmenting cerebral blood flow, an
often neglected but important cause of cerebral ischemia. Finally
and most importantly, physicians continue to prescribe antithrom-
botic and anticoagulant therapy to patients with dissections with-
out good efficacy data or safety data for such treatments. There-
fore, it is arguable that there is no proven, effective therapy for
spontaneous arterial dissections, whether medical or endovascular.
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